Shares of gene-sequencing leader Illumina have fallen 15% from Friday. Rivals 10X Genomics and Pacific BioSciences of ...
Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results tomorrow after market ...
After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...
Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...
Barclays lowered the firm’s price target on 10x Genomics to $18 from $19 and keeps an Overweight rating on the shares. The firm expects the ...
Hosted on MSN20d
Life sciences stocks fall on NIH funding concernsPACB), also known as PacBio, both fell 10%, while Illumina (NASDAQ:ILMN) and Bio-Rad (BIO) shares fell 5% and 4%, respectively. Shares of Qiagen (QGEN) and Bruker (BRKR) slid 3%, with shares of ...
Shares of genetic testing company Illumina and Calvin Klein-owner PVH Corp fell on Tuesday after China placed the two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback